Medical News

RSS

PTSD impairs ability to recognize emotions from facial expressions

Facial expressions convey strong cues for someone's emotional state and the ability to interpret these cues is crucial in social interaction. This ability is known to be compromised in many psychiatric and neurological disorders, such as social anxiety or Korsakoff's syndrome.

17 Aug 2011

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).

17 Aug 2011

Moderate social drinking reduces risk of dementia and cognitive impairment

Moderate social drinking significantly reduces the risk of dementia and cognitive impairment, according to an analysis of 143 studies by Loyola University Chicago Stritch School of Medicine researchers.

17 Aug 2011

GE Healthcare announces acquisition of PAA Laboratories

GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.

17 Aug 2011

People with higher BMI during young adulthood likely to die earlier than others

Those 25-year-olds who are overweight now but think they will be fine as long as they lose weight eventually might need to reconsider. A study appearing online in the Journal of Adolescent Health finds that people who are overweight during young adulthood are likely to die earlier than others.

17 Aug 2011

The growing field of hospital medicine

Hospital medicine is a fast-growing field, attracting many of the young doctors who pursue general internal medicine. It

17 Aug 2011

Obesity directly causes electrical abnormalities of the heart

University of Adelaide research has shown for the first time that obesity directly causes electrical abnormalities of the heart.

17 Aug 2011

Study finds broadest immune response from LAIV nasal spray vaccines for children

Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order, according to researchers funded by the National Institutes of Health.

17 Aug 2011

WSU researcher receives NIH grant to study how chromatin modifiers regulate cell division

The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth.

17 Aug 2011

Moderate alcohol intake on a regular basis may increase risk of obesity

A paper from Spain provides an extensive review of the association between alcohol consumption and body weight. Based on the fact that the energy content in 1 gram of alcohol is 29 kJ or 7.1 kcal, excessive alcohol consumption can lead to weight gain.

17 Aug 2011

JAK protein triggers contractions in tumours and allows cancer cells to spread

Cancer Research UK-funded scientists have discovered that a protein called JAK triggers contractions in tumours which allows cancer cells to squeeze though tiny spaces and spread, in research published in Cancer Cell today.

17 Aug 2011

General Dynamics enters definitive agreement to acquire Vangent

General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.

17 Aug 2011

HSS, pSivida enter orthopedic evaluation agreement

Drug delivery company pSivida Corp. today announced it has entered into an evaluation agreement with Hospital for Special Surgery (HSS), a world leader in orthopedics, rheumatology and rehabilitation, to investigate pSivida's drug delivery technologies in orthopedics.

17 Aug 2011

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

Abbott announced today that the U.S. Food and Drug Administration has approved two new strengths for three-month administration of Lupron Depot-PED (leuprolide acetate for depot suspension) for the treatment of children with central precocious puberty (CPP).

17 Aug 2011

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.

17 Aug 2011

BD acquires Carmel Pharma

BD, a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

From BD (Becton, Dickinson and Company) 17 Aug 2011

State roundup: Health insurance ruling reverberates; Fla. to accept some health law funds; California's aging issues

The state has returned millions in health reform dollars for child and elder care programs, among other things. But on Monday, HHS awarded the Sunshine State $1.26 million in ACA money to bolster efforts to report and combat infectious diseases.

17 Aug 2011

Patrys product shows activity in multiple myeloma cancer cells

Patrys Limited today announced the results of preclinical work conducted at The University Hospital of Würzburg showing the activity of one of Patrys’ products in multiple myeloma.

16 Aug 2011

Fluctuations in brain signals explained: Spontaneous electrical background rhythms in the brain influence fMRI

Until now, brain scans obtained using fMRI – one of the most important imaging methods in use today – have been affected by fluctuations in the brain activity measured which could not be explained. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig and the Charité in Berlin have now shown that certain electric background rhythms in the brain, known as Alpha oscillations, alter the fMRI signal obtained with visual stimuli. To do this, they used a new approach in which quickly changing brain activity, which cannot be captured by the scanner, was measured using

16 Aug 2011

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

LYSOGENE announces the authorization by AFSSAPS (the French Agency for the Safety of Health Products) and by the Ethical Review Board of SAF-301, its leading intra-cerebral gene therapy phase I/II clinical trial aiming at treating Sanfilippo Type A Syndrome.

16 Aug 2011

Medical News

PTSD impairs ability to recognize emotions from facial expressions

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Moderate social drinking reduces risk of dementia and cognitive impairment

GE Healthcare announces acquisition of PAA Laboratories

People with higher BMI during young adulthood likely to die earlier than others

The growing field of hospital medicine

Obesity directly causes electrical abnormalities of the heart

Study finds broadest immune response from LAIV nasal spray vaccines for children

WSU researcher receives NIH grant to study how chromatin modifiers regulate cell division

Moderate alcohol intake on a regular basis may increase risk of obesity

JAK protein triggers contractions in tumours and allows cancer cells to spread

General Dynamics enters definitive agreement to acquire Vangent

HSS, pSivida enter orthopedic evaluation agreement

FDA approves two new strengths of Lupron Depot-PED for central precocious puberty

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

BD acquires Carmel Pharma

State roundup: Health insurance ruling reverberates; Fla. to accept some health law funds; California's aging issues

Patrys product shows activity in multiple myeloma cancer cells

Fluctuations in brain signals explained: Spontaneous electrical background rhythms in the brain influence fMRI

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News